Skip to main content

Thermo Fisher Scientific (TMO) Stock Price & Market Analysis

TMO · NYSE · Medical - Diagnostics & Research

Last confirmed priceEarlier session print

$694.76

▲ +$17.82(+2.63%)4:00 PM ET - vs previous close

Quote as of Nov 6, 2026, 4:00 PM EST

Regular-session close · Nov 6, 2026, 4:00 PM EST.

Last session92%
$661.60L Nov 6 '26$697.78H Nov 6 '26
52-week range94%
$435.27L May 18 '26$712.17H Nov 4 '26
Long-term rangesAvailable history
Available history(2000-11-08)98%
$13.53L Jul 24 '02$712.17H Nov 4 '26

Historical range: 2000-11-08–2026-11-06. Earlier trading may not be included.

Loading price chart…

Data dates

PriceAt closeLast traded

FundamentalsLast checked

AnalystLast checked

NewsLatest item

What matters next

Next important events

  1. Jan 28, 2027Next earnings (est.)Estimated

Countdown

80 days out

Reported fundamentals

TMO financial overview

Annual revenue

USD 44.56B

Sales for the fiscal year ended Dec 31, 2025. This is not trailing twelve-month revenue.

Revenue change

+3.9%

Change versus the fiscal year ended Dec 31, 2024.

Net profit margin

15.0%

Net income divided by revenue for the fiscal year ended Dec 31, 2025. This is not the trailing margin.

These reported results describe the business’s recent scale and profitability. Compare cash generation and valuation before forming an investment view; historical growth is not a forecast.

Company · ProfileAbout Thermo Fisher Scientific (TMO)Sector, leadership, and how Thermo Fisher Scientific earns its revenue.

Thermo Fisher Scientific

NYSE · TMO · US

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Company overview as of Nov 9, 2026.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Headquarters
Waltham, MA, United States
Country
US
Employees
125,000
CEO
Mr. Marc N. Casper
Exchange
NYSE
Business model & operating resultsExplore business exposure, reported operating measures and the figures behind growth and profitability claims.

Company website ↗

Narrative versus numbers

Demand is expanding

Supporting observation: 9.1%

Year-over-year growth in the latest quarter. This differs from the fiscal-year revenue change shown above. · Source timestamp: Sep 26, 2026

Growth produces accounting profit

Supporting observation: 14.9%

Net margin; the source did not supply a reporting period. Do not compare this reading with the quarterly or fiscal-year figures above. A positive margin does not establish cash generation. · Source timestamp: Nov 8, 2026, 10:31 PM EST

The business generates cash after investment

Supporting observation: USD 2.11B

Latest free cash flow from the statement feed. It is not a forecast and may cover a different period from the fiscal-year figures above. · Source timestamp: Sep 26, 2026

These are explicit tests of individual claims, not an overall bull/bear rating. Demand growth can coexist with valuation, concentration and financing risk.

Operating measures

Revenue
$12.14Bquarter ended Sep 26, 2026
Operating margin
18.6%quarter ended Sep 26, 2026
EPS
$4.64quarter ended Sep 26, 2026
Capital expenditure
$437.00Mquarter ended Sep 26, 2026
Free cash flow
$2.11Bquarter ended Sep 26, 2026
Free cash flow margin
17.4%quarter ended Sep 26, 2026
Operating cash / net income
1.48×quarter ended Sep 26, 2026
Revenue growth year over year
9.1%quarter ended Sep 26, 2026
Competitors & comparisonsCompare industry peers, reporting periods and related funds. Business mix and valuation bases may differ.
Valuation & fund comparisonsExplore dated peer valuations, growth comparisons and related funds.

Governance & sustainability

Find proxy statements and annual reports

Data sources: Financial Modeling Prep · Finnhub · SEC Companyfacts · Yahoo Finance

Market data is for information only and is not trading advice. Prices and fundamentals may be delayed, reflect an earlier observation, be incomplete, or be revised. Read the data methodology or the full disclaimer.
Research tools
Premarket

Regular hours: 9:30 AM–4:00 PM America/New_York

Next open: 2026-11-09 · 9:30 AM America/New_York

Exchange calendar includes scheduled holidays and early closes. Extended-session prices appear separately only when supplied by the quote source.